Gary Blackford, Independent Chairman of Avanos Medical, recently bought 84% more shares for $659k at $10.99, boosting their holding. This is the largest insider purchase in the last year and implies optimism about the company. However, insider ownership is low at 1.8%, and the company did not make a profit in the last 12 months.
Independent Chairman Gary Blackford of Avanos Medical, Inc. (AVNS) recently made a notable insider purchase, buying an additional 60,000 shares at a cost of $10.99 each, totaling $659,300. This transaction, reported on August 13, 2025, represents a significant increase in Blackford's holding, boosting his stake by 84% [1].
The purchase price of $10.99 per share is slightly above the company's average trading price of $10.975 for the day, indicating a potential optimism from Blackford regarding Avanos Medical's future prospects. This is the largest insider purchase in the past year, suggesting that Blackford and possibly other insiders are bullish on the company's performance.
Despite the insider buying, Avanos Medical's insider ownership remains relatively low at 1.8%, according to the latest SEC filings. The company's stock has been trading up about 0.7% on Friday, August 15, 2025, following the insider purchase [2].
However, it is important to note that Avanos Medical did not report a profit in the last 12 months, which could be a concern for investors. The company's financial performance and the reasons behind the insider buying will need to be closely monitored to gauge the impact on the stock price.
References:
[1] https://www.stocktitan.net/sec-filings/AVNS/form-4-avanos-medical-inc-insider-trading-activity-306515f62405.html
[2] https://www.nasdaq.com/articles/friday-8-15-insider-buying-report-psx-avns
Comments
No comments yet